synchronization or differentiation properties, validating the overall utility of our 57 model system, to recapitulate not only key features of human somitogenesis but also 58 to provide novel insights into diseases associated with the formation and patterning 59 of the human axial skeleton.
the HES7-reporter in our human PSM samples (Fig. 1g ) and determined the period of the 82 human segmentation clock to be 5-6 hours, which is similar to the 4-6 hour period 83 reported for somite formation in primary human embryo samples 9,10 . To our knowledge, 84 this is the first real-time observation of oscillatory expression in the human segmentation 85 clock.
86
We then asked, whether we could also observe traveling wave-like expression, 87
another hallmark of the segmentation clock, which is caused by the synchronization 88 among oscillations in neighboring cells. Such traveling waves have been reported in the 89 context of explant studies utilizing reporter mice and mouse ESC-derived PSM 11,12 , but 90 have never been observed in human PSM. Using a sphere of human PSM induced in 3D 91 culture, we could see sustained oscillation and the clear presence of traveling waves 92 (Extended Data Movie 1), which is also indicated by the tilted slope in the kymograph 93 (Fig. 1h ).
94
In order to ensure that our in vitro-derived PSM is indeed comparable to its in 95 vivo counterpart, we further characterized its differentiation capacity into somitic 96 mesoderm, sclerotome and dermomyotome. To induce somitic mesoderm we mimicked 97 the decrease in Fgf and Wnt activity along the posterior-anterior axis of the PSM reported 98 in the embryonic context 13 , by simultaneous inhibition of both pathways, leading to the 99 rapid and robust induction of somitic mesoderm expressing TCF15, a well established 100 marker of somite development 14 , at the transcript ( derived from a calcium reporter iPSC line (Gen1C) revealed the reproducible presence of 120 beating skeletal muscle cells after three weeks of in vitro 2D differentiation culture ( Fig.  121 1j, Extended Data Movie 2). We thus showed that our in vitro step-wise induction 122 protocol can give rise to human PSM cells and their proper derivatives that appear to 123 recapitulate key features of their corresponding developmental counterparts and 124 respective embryological stages.
125
Since the oscillation and synchronization in human PSM have never been 126 characterized before, we asked whether we could deepen our understanding of the human 127 segmentation clock even further, using the experimental system at hand. To this end we 128 collected PSM samples during oscillation by monitoring the oscillatory activity of the 129 HES7-reporter (Extended Data Fig. 3a ) and performed RNA-seq analysis of the isolated 130 RNA samples (16 samples each for two independent sets of experiments).
131
Our NGS-based analysis of the different PSM time-points revealed a core-set of 132 about two hundred oscillating genes (Fig. 2a , Extended Data Table 2 ). Pathway and gene 133 ontology (GO) analysis of the identified gene clusters revealed that in addition to 134 enrichment of pathway members previously associated with the segmentation clock, such 135 as Notch, Wnt or Fgf signaling 16, 17 novel pathways were also represented in our data set, 136 including members of the TGFβ pathway or Hippo signaling (Fig. 2b , Extended Data Fig.  137 3b, Extended Data Table 3 ). Interestingly, the Hippo pathway component YAP was 138 recently reported to be an important regulator of oscillatory activity in mouse PSM 18 , 139
suggesting that this role might be conserved in human PSM, which showed oscillatory 140 activity of core Hippo pathway components (TEAD4, AMOTL2) ( 
143
Oscillatory expression of HOXD1 was previously shown during somitogenesis in 144 mouse 19 suggesting that its expression pattern and biological function might be conserved 145 in human PSM. We could also identify oscillation of putative modulators of the 146 cytoskeleton (ARHGAP24, ARHGEF2, RHOU, PLEKHG2) as well as histone modifiers 147 (KDM6B, JADE1) as oscillating genes (Fig. 2a, 2c , Extended Data Fig. 3b ). The 148 intriguing possibility that above-mentioned cytoskeleton associated oscillating genes 149 might represent a link between the segmentation clock and the actual process of 150 segmentation, characterized by mesenchymal to epithelial transition and associated with 151 major cytoskeletal rearrangements, remains to be elucidated. Furthermore, identification 152 of oscillating histone modifiers in the PSM, suggests a possible role of epigenetic 153 modifications in the regulation or maintenance of the segmentation clock, and will be the 154 topic of future research efforts.
155
Among the identified oscillatory genes, two thirds were oscillating in phase with 156 HES7 (142) and about one third (77) showing an anti-phase oscillatory expression pattern 157 (Fig. 2a , Extended Data Table 2 ). The phase cluster of human oscillating genes contained 158 Notch-pathway associated genes such as LFNG 20 , while the anti-phase cluster contained 159
Wnt-pathway associated negative feedback regulators such as DKK1 and SP5 21, 22 (Fig.  160 2a, 2c), as previously reported for posterior PSM of mouse embryos 23 . Generating a dual 161 luciferase-activity based reporter line for DKK1 and HES7 promoter activities we 162 confirmed clear phase and anti-phase reporter oscillations in human iPSC-derived PSM 163 samples (Fig. 2d) , suggesting that our induced PSM may represent posterior immature 164 PSM rather than anterior mature PSM.
165
In order to also show the utility of our system to model anomalies during human 166 axial skeletogenesis such as SCD or STD, known to be caused by mutations in genes 167 associated with the segmentation clock (e.g. HES7, LFNG, DLL3 and MESP2) 24 , we 168 utilized CRISPR/Cas9-mediated genome editing technology to generate knock-out 169 reporter iPSC lines aiming to induce frameshifts or deletion mutations in these target 170 genes in the HES7 luciferase reporter line background (Extended Data Fig. 4 ) and 171
analyzed their putative loss-of-function effect on oscillatory HES7-reporter activity. 172
Knock-out of endogenous HES7 itself led to complete loss of oscillatory activity of the 173 HES7-reporter, in a 2D-oscillation assay (Fig. 3a) , similar to previous embryological 174 studies utilizing knock-out mice 25 . Interestingly knock-out reporter lines for LFNG, DLL3 175 or MESP2 continued to show strong oscillatory HES7 activity (Fig. 3b ) even though 176 knock-out mice for LFNG and DLL3 were reported to show defective oscillation 177 patterns 20, 26 . We reasoned that in this 2D-oscillation assay the phase (i.e. timing) of 178 oscillations is initially reset by medium change, showing collective oscillation even in the 179 absence of a strong synchronization mechanism. We then examined the synchronization 180 ability of knock-out reporter lines of aforementioned genes using 3D-spheres of PSM 181 (Fig. 3c) Fig. 5c ).
201
Taken together, these results underline the overall value of an higher order assay 202 system that can assess not only gene or protein expression but also more complex 203 features such as oscillation or synchronization in human PSM, thus opening up the path 204 to work out functionally relevant and possibly disease-associated features specific to each 205 loss-or gain-of-function mutation, otherwise not accessible.
206
To further evaluate the utility of our experimental model system to assess not only 207 key features of the human segmentation clock and somitogenesis but also address 208 causative molecular mechanisms associated with diseases affecting axial skeletogenesis, 209
we established iPSC lines from 12 individuals afflicted by SCD or STD (data not shown).
210
In one of the established STD patient-derived iPSC lines (Extended Data Fig. 6 ) we 211 identified via Exome sequencing compound heterozygous loss-of-function mutations in 212 MESP2 (rs1452984345: c.256delGCCA, p.fsTer118; rs71647808: c.307T, p.E103X) 213 (Fig. 4a) . Induction of PSM from these patient iPSCs (STD-A and STD-F; two different 214 iPSC clones from the same patient) appeared to be not affected, as assessed by flow 215 cytometric analysis of DLL1 expression ( Fig. 4b ; Extended Data Fig. 7a ). We observed 216
for the patient line (STD-A) harboring MESP2 loss-of-function mutations, clear 217 oscillatory activity of HES7 in 2D-oscillation assay (Fig. 4c) , similar to what we saw for 218 our human MESP2 knock-out reporter lines (Fig. 3b) . In the 3D-synchronization assay 219 this patient line also showed sustained collective oscillation and occasional traveling 220 waves, indicating an intact synchronization mechanism (Fig. 4d) , again similar to results 221 seen for MESP2 knock-out lines (Fig. 3c) . In order to facilitate the molecular and 222 functional analysis of our patient lines, we generated isogenic controls by correcting the 223 underlying putative disease causing mutations via gene targeting with CRISPR/Cas9. 224
Allele-specific gene correction of MESP2 was achieved using sgRNAs targeting either 225 the c.256delGCCA or c.307T mutation and homologous recombination with donor 226 vectors bearing normal MESP2 gene sequence. Microhomology-assisted excision 227 (MhAX) was used to remove the selection cassette 28 (Fig. 4e, 4f , Extended Data Fig. 8 ), 228 thus effectively rescuing the disease-causing loss of MESP2, albeit heterozygously. 229
Gene-edited iPSCs were confirmed to be karyotypically similar to the parental patient 230 iPSC line (Extended Data Fig. 9 ). As no clear oscillation or synchronization phenotype 231 could be observed for the analyzed patient line, we asked whether we could see possible 232 differences at the functional or molecular level by comparing patient (STD-A and STD-233 F) and corresponding rescued iPSC lines (STD-resA and STD-resF). To this end we 234 induced and compared all stages of our in vitro induction and differentiation protocol via 235 RNA-seq analysis using patient and rescue lines (Fig. 4g , Extended Data Fig. 7b ).
236
Comparison of patient clones with wild-type (healthy) and heterozygously 237 corrected lines revealed the presence of an up-regulated gene cluster at the somitic 238 mesoderm stage in the analyzed patient lines, which could be reversed upon correction of 239 either mutated allele (Fig. 4g) . Genes apparently up-regulated in patient somitic 240 mesoderm and reduced upon rescue of either MESP2 mutation, included FGF4, FGF18 241 and DUSP5 (Fig. 4g, 4h ), indicating abnormal Fgf signaling as a possible novel disease 242 associated molecular feature in STD. MESP2 knock-out iPSC-derived somitic mesoderm 243 samples also showed higher levels of expression of FGF4, FGF18 and DUSP5 (Fig. 4h ).
244
Interestingly human EPHA3, which was previously reported to have a dominant negative 245 effect on somite formation and axial organization in fish 29 , was also found to be up-246 regulated in STD-patient and MESP2-knock-out derived somitic mesoderm (Fig. 4g, 4h ). 
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Step-wise induction of human somitic mesoderm 501
Human iPSCs were seeded on iMatrix-511 silk-coated plates or dishes at appropriate 502 densities as single cells (e.g. 1.3 × 10 4 cells/well into 6 well plate; 8.0 × 10 4 cells/dish 503 into 10 cm dish) 5 days before induction. All differentiation and induction steps were 504 performed in chemically defined medium with insulin (CDMi) 33 if not otherwise 505 mentioned. Our step-wise protocol is similar to a recently published mesoderm induction 506 protocol 4 , albeit with some differences. Human primitive streak (PS) cells were induced 507 by treatment of iPSCs with bFGF (20 ng/ml), CHIR99021 (10 µM) and Activin A (50 508 ng/ml) for 24 hours. Presomitic mesoderm (PSM) cells were induced from PS cells by 509 exposure to SB431542 (10 µM), CHIR99021 (3 µM), LDN193189 (250 nM) and bFGF 510 (20 ng/ml) for 24 hours. Subsequently, somitic mesoderm (SM) cells were induced from 511 PSM cells using PD173074 (100 nM) and XAV939 (1 µM) for 24 hours. For details of 512 used recombinant human proteins and small molecule agonists or inhibitors see Extended 513
Data Table 4 . 514 515
Human sclerotome and dermomyotome induction 516
Following initial step-wise somitic mesoderm (SM) induction, human sclerotome (SCL) 517 cells were induced with combination of SAG (100 nM) and LDN193189 (600 nM) 34 for 518 72 hours. Dermomyotome (DM) cells were induced from human somitic mesoderm as 519 previously described 4 , using a combination of CHIR99021 (3 µM), GDC0449 (150 nM) 520 and BMP4 (50 ng/ml) for 48 hours. 521 522
In vitro 3D-chondrogenic induction (3D-CI) 523
Step-wise induced human sclerotome (SCL) cells were dissociated using Accutase (Life Reporter constructs 609
For the HES7-reporter, human HES7 promoter (5937 bp) and 3'UTR were fused to 610
Luciferase2-NLS-d1PEST 38 . For the dual reporter assay, the HES7 promoter and 3'UTR 611 were fused to NanoLuc-NLS-d1PEST, while human DKK1 promoter (2218 bp) and 612 3'UTR were fused to Luciferase2-NLS-d1PEST. These reporters were integrated into the 613 genome using piggyBac transposition. See Fig. 1g and Fig. 2d for schematic overviews of 614 used reporter constructs. 615 616
2D-oscillation assay 617
Luminescence was measured in the presence of D-luciferin (200 µM) with Kronos Dio 618
Luminometer (Atto). For the dual reporter assay, HES7-and DKK1-reporter constructs 619 were simultaneously introduced into the cells, and each luminescence was filtered and 620 measured in the presence of Furimazine (400 nM) and D-luciferin (1 mM). HES7-621 reporter cells were seeded on a 35 mm dish coated with iMatrix-511 at 3000 cells/dish.
622
After 4 days culture, medium was changed into CDMi containing SB431542 (10 µM), 623 DMH1 (2 µM), CHIR99021 (10 µM) and bFGF (20 ng/ml). After additional 3 days 624 culture, the medium was changed into CDMi without inhibitors for measurement with 625
Kronos Dio Luminometer (Atto). This (modified) one-step protocol 39 was used for Fig.  626 1g and 2d. All other oscillation measurements were performed using our standard step-627 wise PSM induction protocol. 628 629
3D-synchronization assay 630
To make 3D cell spheres, HES7-reporter iPSCs were seeded into non-adhesive round 631 bottom 96 well plates at 1000-3000 cells/well and cultured in CDMi containing BMP4 632 (50 ng/ml), CHIR99021 (10 µM) and Y27632 (10 µM). After one day of culture, Y27632 633 was removed. After 18 hours culture the medium was changed into CDMi containing 634 DMH1 (2 µM) and CHIR99021 (10 µM). After 6 hours culture, the cell sphere was 635 transferred to a fibronectin-coated glass bottom dish with CDMi containing DMH1 (2 636 µM) and D-luciferin (1 mM), and luminescence was imaged with a customized incubator 637 microscope LCV110 (Olympus gene were normalized to mean of all samples. The gene order is the same as in Fig. 1b 
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